JPS6136226A - アンジオテンシン転換酵素阻害剤 - Google Patents

アンジオテンシン転換酵素阻害剤

Info

Publication number
JPS6136226A
JPS6136226A JP59158324A JP15832484A JPS6136226A JP S6136226 A JPS6136226 A JP S6136226A JP 59158324 A JP59158324 A JP 59158324A JP 15832484 A JP15832484 A JP 15832484A JP S6136226 A JPS6136226 A JP S6136226A
Authority
JP
Japan
Prior art keywords
inhibitor
trypsin
treating
casein
angiotensin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59158324A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6151562B2 (enExample
Inventor
Susumu Maruyama
進 丸山
Noboru Tomizuka
冨塚　登
Hideo Suzuki
英雄 鈴木
Akio Sato
昭生 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP59158324A priority Critical patent/JPS6136226A/ja
Publication of JPS6136226A publication Critical patent/JPS6136226A/ja
Publication of JPS6151562B2 publication Critical patent/JPS6151562B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP59158324A 1984-07-28 1984-07-28 アンジオテンシン転換酵素阻害剤 Granted JPS6136226A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59158324A JPS6136226A (ja) 1984-07-28 1984-07-28 アンジオテンシン転換酵素阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59158324A JPS6136226A (ja) 1984-07-28 1984-07-28 アンジオテンシン転換酵素阻害剤

Publications (2)

Publication Number Publication Date
JPS6136226A true JPS6136226A (ja) 1986-02-20
JPS6151562B2 JPS6151562B2 (enExample) 1986-11-10

Family

ID=15669148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59158324A Granted JPS6136226A (ja) 1984-07-28 1984-07-28 アンジオテンシン転換酵素阻害剤

Country Status (1)

Country Link
JP (1) JPS6136226A (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62270533A (ja) * 1986-05-20 1987-11-24 Agency Of Ind Science & Technol 経口摂食物
US5314807A (en) * 1991-03-29 1994-05-24 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method for producing an angiotensin converting enzyme inhibitor-containing composition
US5369015A (en) * 1991-10-17 1994-11-29 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method for producing an angiotensin converting enzyme inhibitor-containing composition
KR100470456B1 (ko) * 2001-07-02 2005-02-05 대한민국 혈압 저하 효과가 있는 카제인 단백질 분해물 및 그제조방법
EP1938832A1 (en) 2003-03-18 2008-07-02 Suntory Limited Angiotensin-converting enzyme inhibitory peptides
US7550436B2 (en) 2000-05-11 2009-06-23 Kracie Pharma, Ltd. Compositions containing peptide and electrolyte excretion promoter and foods containing the same
WO2009033737A3 (en) * 2007-09-11 2009-09-03 Mondobiotech Laboratories Ag Use of gluten exorphin c : as a therapeutic agent
WO2011039999A1 (ja) 2009-10-02 2011-04-07 株式会社 ファイナルフューチャーインターナショナル 脂肪分解促進作用を有する組成物

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62270533A (ja) * 1986-05-20 1987-11-24 Agency Of Ind Science & Technol 経口摂食物
US5314807A (en) * 1991-03-29 1994-05-24 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method for producing an angiotensin converting enzyme inhibitor-containing composition
US5369015A (en) * 1991-10-17 1994-11-29 Nippon Gohsei Kagaku Kogyo Kabushiki Kaisha Method for producing an angiotensin converting enzyme inhibitor-containing composition
US7550436B2 (en) 2000-05-11 2009-06-23 Kracie Pharma, Ltd. Compositions containing peptide and electrolyte excretion promoter and foods containing the same
KR100470456B1 (ko) * 2001-07-02 2005-02-05 대한민국 혈압 저하 효과가 있는 카제인 단백질 분해물 및 그제조방법
EP1938832A1 (en) 2003-03-18 2008-07-02 Suntory Limited Angiotensin-converting enzyme inhibitory peptides
US7833985B2 (en) 2003-03-18 2010-11-16 Suntory Holdings Limited Angiotensin-converting enzyme inhibitory peptides
US7943578B2 (en) 2003-03-18 2011-05-17 Suntory Holdings Limited Angiotensin-converting enzyme inhibitory peptides
WO2009033737A3 (en) * 2007-09-11 2009-09-03 Mondobiotech Laboratories Ag Use of gluten exorphin c : as a therapeutic agent
JP2010539029A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのグルテンエキソルフィンＣ（ＧｌｕｔｅｎＥｘｏｒｐｈｉｎＣ）の使用
WO2011039999A1 (ja) 2009-10-02 2011-04-07 株式会社 ファイナルフューチャーインターナショナル 脂肪分解促進作用を有する組成物
US9399043B2 (en) 2009-10-02 2016-07-26 Final Future International, Inc. Composition having lipolysis-promoting effect

Also Published As

Publication number Publication date
JPS6151562B2 (enExample) 1986-11-10

Similar Documents

Publication Publication Date Title
US4816449A (en) Immunotherapeutic anti-inflammatory peptide agents
Blombäck [44] Derivatives of glutamine in peptides
US3778426A (en) Therapeutically useful polypeptides
US4189604A (en) Bestatin
JPH0742311B2 (ja) ＣＨＬ‐Ｃｕの化学的誘導体
US4056520A (en) Clinically active bovine growth hormone fraction
US4628045A (en) Immunotherapeutic antiallergic polypeptide agents which bind to basophil immunoglobin Fc receptors
JP3318622B2 (ja) プロリルエンドペプチダーゼ阻害剤
JPH07188282A (ja) 新規なトリペプチド、その製法およびそれを有効成分と する血圧降下剤
JPS6023086B2 (ja) アンジオテンシン転換酵素阻害剤
EP0348086B1 (en) Novel peptides, their use as immuno suppressants and processes for their preparation
US4631270A (en) Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use
JPS6151562B2 (enExample)
JPS6023085B2 (ja) アンジオテンシン転換酵素阻害剤
JPS6023087B2 (ja) アンジオテンシン転換酵素阻害剤
US3904753A (en) Clinically active bovine growth hormone fraction
JPH04266899A (ja) ヒトリポコルチンから誘導される合成ペプチド及びその用途
SU1232148A3 (ru) Способ получени инсулина человека
HU184041B (en) Process for preparing glucopyranosyl-peptides
JPS6136227A (ja) アンジオテンシン転換酵素阻害剤
JP2008539204A (ja) 血圧降下タンパク質加水分解物
JPH08269087A (ja) 新規なテトラペプチド、ペンタペプチドその製法およびそれらを有効成分とする血圧降下剤
JPH03251543A (ja) アンジオテンシン変換酵素阻害剤
JP3110075B2 (ja) アンギオテンシン変換酵素阻害剤含有組成物の製造方法
US4637997A (en) Hexapeptide, process for obtaining II and the pharmaceutical compositions containing II

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term